PRISM CHAGAS 07K35-68

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2013-09-12 for PRISM CHAGAS 07K35-68 manufactured by Abbott Laboratories.

Event Text Entries

[3807541] The customer reports three falsely reactive prism chagas assay results on donor samples. The three samples tested negative by ripa confirmation testing. The customer could not provide any individual specific donor testing information. The customer noted that their initial reactive (0. 32%)and repeat reactive rates (0. 23%) for (b)(6) 2013, exceeded assay package insert claims of 0. 28% and 0. 22% respectively. The customer noted that there were no changes in their testing process. The majority of samples were fresh serum with possibly a few fresh plasma samples. All donors were being tested for the first time for chagas. The customer stated that the current and previous reagent lots have had no issues and are performing as expected. No suspect results had been reported from the lab with no donor impact.
Patient Sequence No: 1, Text Type: D, B5


[11094119] An evaluation is in process. A follow up report will be submitted when the evaluation is complete. (b)(4). An evaluation is in process.
Patient Sequence No: 1, Text Type: N, H10


[26492631] Further investigation of the customer issue included a review of historical and complaint data, a review of device history records, review of labeling and review of field clinical specificity data. Review of the data did not identify any product issue or adverse trend. Labeling was reviewed and found to be adequate. An analysis of the field data reported to the prism metrics database for abbott prism chagas reagent lot 23242m501 and base lot 23242m500, which contains the same material contributing to product performance was analyzed. A total of (b)(4) samples had been tested for these lots across multiple customer sites at the time of the review. The overall initial and repeat reactive rates were calculated to be 0. 15% and 0. 12%, respectively. These initial and repeat reactive rates were less than the abbott prism chagas package insert ((b)(4)) upper 95% confidence intervals of 0. 28% and 0. 23%, respectively. As a result, the lot is meeting labeling claims for clinical specificity. Based on the results of this investigation, no malfunction or deficiency was identified.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1415939-2013-00337
MDR Report Key3344819
Report Source05
Date Received2013-09-12
Date of Report2013-08-20
Date Mfgr Received2013-09-30
Device Manufacturer Date2013-01-01
Date Added to Maude2013-12-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone847937-512
Manufacturer G1ABBOTT LABORATORIES
Manufacturer Street100 ABBOTT PARK ROAD
Manufacturer CityABBOTT PARK IL 60064350
Manufacturer CountryUS
Manufacturer Postal Code60064 3500
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePRISM CHAGAS
Product CodeMIU
Date Received2013-09-12
Catalog Number07K35-68
Lot Number23242M501
OperatorOTHER
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT LABORATORIES
Manufacturer Address100 ABBOTT PARK ROAD ABBOTT PARK IL 60064350 US 60064 3500


Patients

Patient NumberTreatmentOutcomeDate
10 2013-09-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.